ARIX.L Regulatory News (ARIX)

ARIX.L Information

There is currently no data for ARIX

PDMR Notification & Director Shareholding

3 Nov 2023 16:30

Arix Bioscience PLC (ARIX) PDMR Notification & Director Shareholding 03-Nov-2023 / 16:30 GMT/BST

Arix Bioscience plc("Company")

PDMR Notification & Director Shareholding

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

The Company has been notified that Peregrine Moncreiffe, Director and Chairman of the Company purchased 40,000 Ordinary shares of 0.001 pence each in the Company (“Shares”) on 3rd November 2023 at a price of £1.15 per share.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Peregrine Moncreiffe
2	Reason for the notification
a)	Position/status	Non-Executive Director and Chair of the Board
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Arix Bioscience plc
b)	LEI	213800OVT3AHQCXNIX43
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Arix Bioscience plc Ordinary shares of 0.001 pence each
	Identification code	GB00BD045071
b)	Nature of the transaction	Share purchase
c)	Price(s) and volume(s)		Price(s)£	Volume(s)
			1.15	40,000
d)	Aggregated information
	- Aggregated volume	40,000
	- Price	£46,000.00
e)	Date of the transaction	3 November 2023
f)	Place of the transaction	Outside a trading venue

For further information please contact: Kin Company Secretarial Limited, Company Secretary+44 20 8819 6486

Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


ISIN:	GB00BD045071
Category Code:	DSH
TIDM:	ARIX
LEI Code:	213800OVT3AHQCXNIX43
OAM Categories:	3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.:	282725
EQS News ID:	1765125


End of Announcement	EQS News Service

UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date		Source	Headline
28th May 2021	4:56 pm	EQS	Transaction in own shares
27th May 2021	4:58 pm	EQS	Transaction in own shares
26th May 2021	4:53 pm	EQS	Transaction in own shares
25th May 2021	5:24 pm	EQS	Transaction in own shares
24th May 2021	5:04 pm	EQS	Transaction in own shares
21st May 2021	5:09 pm	EQS	Transaction in own shares
20th May 2021	5:27 pm	EQS	Transaction in own shares
20th May 2021	7:00 am	EQS	Change of registered office
19th May 2021	5:06 pm	EQS	Transaction in own shares
18th May 2021	5:33 pm	EQS	Transaction in own shares
18th May 2021	7:00 am	EQS	Notice of 2021 Annual General Meeting
17th May 2021	5:40 pm	EQS	Transaction in own shares
14th May 2021	5:02 pm	EQS	Transaction in own shares
13th May 2021	5:16 pm	EQS	Transaction in own shares
12th May 2021	5:12 pm	EQS	Transaction in own shares
12th May 2021	4:35 pm	EQS	Autolus to present additional data in AUTO1 in IBCL
11th May 2021	5:43 pm	EQS	Transaction in own shares
10th May 2021	5:21 pm	EQS	Transaction in own shares
7th May 2021	5:19 pm	EQS	Transaction in own shares
6th May 2021	5:23 pm	EQS	Transaction in own shares
5th May 2021	5:16 pm	EQS	Transaction in own shares
4th May 2021	5:15 pm	EQS	Transaction in own shares
4th May 2021	7:00 am	EQS	Total Voting Rights
30th Apr 2021	4:59 pm	EQS	Transaction in own shares
30th Apr 2021	7:00 am	EQS	Outcome of Strategic Implementation Review and Directorate Change
29th Apr 2021	5:10 pm	EQS	Transaction in own shares
28th Apr 2021	5:14 pm	EQS	Transaction in own shares
28th Apr 2021	12:02 pm	EQS	Amplyx Pharmaceuticals acquired by Pfizer
27th Apr 2021	5:29 pm	EQS	Transaction in own shares
27th Apr 2021	2:00 pm	EQS	LogicBio announces clinical and corporate updates
26th Apr 2021	5:32 pm	EQS	Transaction in own shares
23rd Apr 2021	5:11 pm	EQS	Transaction in own shares
22nd Apr 2021	5:15 pm	EQS	Transaction in own shares
21st Apr 2021	5:27 pm	EQS	Transaction in own shares
20th Apr 2021	5:31 pm	EQS	Transaction in own shares
19th Apr 2021	5:09 pm	EQS	Transaction in own shares
16th Apr 2021	5:18 pm	EQS	Transaction in own shares
15th Apr 2021	5:09 pm	EQS	Transaction in own shares
14th Apr 2021	5:13 pm	EQS	Transaction in own shares
13th Apr 2021	5:13 pm	EQS	Transaction in own shares
12th Apr 2021	5:23 pm	EQS	Transaction in own shares
9th Apr 2021	5:44 pm	EQS	Transaction in own shares
8th Apr 2021	5:28 pm	EQS	Transaction in own shares
8th Apr 2021	8:19 am	RNS	Proactive One2One Virtual Investor Forum
8th Apr 2021	7:00 am	EQS	Arix to Present at the Proactive One2One Virtual Investor Forum
7th Apr 2021	5:47 pm	EQS	Transaction in own shares
7th Apr 2021	7:00 am	EQS	Artios announces collaboration with Novartis to create next generation DDR cancer therapies
6th Apr 2021	5:26 pm	EQS	Transaction in own shares
1st Apr 2021	5:20 pm	EQS	Transaction in own shares
1st Apr 2021	7:00 am	EQS	Total Voting Rights

Latest Share Chat

ARIX.L Regulatory News (ARIX)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PDMR Notification & Director Shareholding

Login to your account

Quickpicks are a member only feature

Login to your account